 |
|
COMMENTS AND OPINIONS
Is Aspirin Resistance Due to Noncompliance?—Reply
Jaapjan D. Snoep, MSc;
Marcel M. C. Hovens, MD;
Jeroen C. J. Eikenboom, MD, PhD;
Johanna G. van der Bom, MD, PhD;
Menno V. Huisman, MD, PhD
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In reply
Heterogeneity is often an important problem in meta-analyses and complicates drawing overall conclusions. As correctly pointed out by Fontana and Reny in their letter and also acknowledged in the "Comment" section of our systematic review on the clinical consequences of laboratory aspirin resistance,1 the studies in our review are heterogeneous in many ways, regarding, for example, study population and definition of aspirin resistance. This is probably reflected by the statistical heterogeneity present in the pooled analysis, though, parenthetically, it would not be ruled out by statistical homogeneity.
Despite this heterogeneity, we believe that we can reasonably conclude that laboratory aspirin resistance seems to be associated with recurrent cardiovascular events because our main conclusions are based on a critical appraisal of the . . . [Full Text of this Article]
AUTHOR INFORMATION
RELATED ARTICLE
Association of Laboratory-Defined Aspirin Resistance With a Higher Risk of Recurrent Cardiovascular Events: A Systematic Review and Meta-analysis
Jaapjan D. Snoep, Marcel M. C. Hovens, Jeroen C. J. Eikenboom, Johanna G. van der Bom, and Menno V. Huisman
Arch Intern Med. 2007;167(15):1593-1599.
ABSTRACT
| FULL TEXT
RELATED LETTER
Is Aspirin Resistance Due to Noncompliance?
James E. Dalen
Arch Intern Med. 2008;168(5):550.
EXTRACT
| FULL TEXT
|
